Loncar Cancer Immunotherapy ETF (CNCR)

9.02 ↑0.00 (0.00%)
As of December 31, 1969, 7:00pm EST.

CNCR Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $8.01 - $16.11
  • Market Capitalization: $0
  • Short Percentage: 0%
  • Target Price: N/A
  • Shares Outstanding: 0
  • Next Earnings: N/A
View More Stats

Catalysts

DateCategoryCatalyst
Help your fellow traders

Company Info

Website: N/A
Address: N/A
Sector: N/A
Industry: N/A
Full time employees: N/A

Stock Details

  • Current Price: $9.02
  • 52-Week Low: $8.01
  • 52-Week High: $16.11
  • Most Recent Quarter: 0000-00-00
  • Shares Float: 0
  • Shares Outstanding: 0
  • Market Capitalization: $0
  • Next Earnings Date: N/A

Short Interest

  • Shares Short
    (Today):
    0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):
    0
  • Short Interest: 0.00%

The short interest for Loncar Cancer Immunotherapy ETF is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 100.00%
Insiders: 0.00%
Instutitions: 0.00%

Analyst Target Price

0.00

Loncar Cancer Immunotherapy ETF is currently $9.02 above Wallstreet Analysts' price target.

Yesterday's Volume

3,077

Interest in Loncar Cancer Immunotherapy ETF has been trending up. The average daily volume in the past 14 days is 2,291.

Discussions

Please log in or register to share your thoughts.

a

$CNCR It's happening!

0 Like Report